SUMERA CHAGGAN: Open Payments
NPI 1144702887 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 14 payments from 7 companies in 2025. Trend: 2023 $1,126 · 2024 $780 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $252 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $30 |
| SCILEX PHARMACEUTICALS INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Abbott Laboratories | 1 | $16 |
Products named: WaveWriter Alpha Prime 16, VERQUVO, JOURNAVX, RELISTOR, ZTLido, MOUNJARO, IONICRF.
Industry payments across CA — which companies pay providers there.
